Genomic Vision Reports Unaudited Revenue Results for the Fourth Quarter and Full Year Ended December 31, 2022
For the full year Total revenue from activity was 1,480,000 against 1,413,000 reported a year ago.
1st Jan change | Capi. | |
---|---|---|
+22.15% | 46.56B | |
+44.93% | 41.67B | |
-2.37% | 41.16B | |
+33.84% | 32.4B | |
-6.35% | 28.1B | |
+20.42% | 28.18B | |
+48.83% | 14.52B | |
+45.00% | 13.74B | |
+0.06% | 12.17B |